menu title
Title
Presentation Series: HIV ECHO
-
Data on medications to address methamphetamine use
-
HIV testing considerations for people on CAB-LA…
-
-
-
Summary of HIV co-morbidity studies presented at…
-
How to integrate long-acting injectable ART into…
-
2020 HIVMA HIV primary care guidance continued
-
Isolated hepatitis B core antibody positivity in…
-
Diabetes Type 2 medications and people with HIV
-
-
How COVID adapatations may affect PrEP provision…
-
Update on 2021 DHHS HIV treatment guidelines
-
More regulatory changes and important…
-
Updated 2021 CDC STI treatment guidelines on…
-
Diabetes Type 2 medications and people with HIV
-
Interactions between ART medications for HIV and…
-
Dr. Landovitz discusses HPTN 083, an efficacy…
-
-
Overview of Fostemsavir, a recently approved…
-
HIV PEP/PrEP case scenarios
-
-
2020 IAS-USA HIV prevention guidelines update
-
nPEP guidelines, access barriers, and potential…
-
